1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Jiangsu Nhwa Pharmaceutical Co., LTD
  6. Company
    002262   CNE100000CG8

JIANGSU NHWA PHARMACEUTICAL CO., LTD

(002262)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Jiangsu Nhwa Pharmaceutical Co., LTD is a China-based company principally engaged in the production and sales of pharmaceutical preparations. The Company offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The Company is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The Company distributes its products within domestic market and to overseas markets.

Number of employees : 4 732 people.
Sales per Business
20202021Delta
Manufacturing2 947.0187.7%3 454.8287.8% +17.23%
Commercial368.8311%420.6310.7% +14.04%
Other45.461.4%60.211.5% +32.44%
CNY in Million
Sales per region
20202021Delta
China3 320.8998.8%3 912.8699.4% +17.83%
International23.420.7%22.800.6% -2.65%
CNY in Million
Managers
Name Title Age Since
Jia Quan Sun General Manager & Director 45 2010
Ai Hao Gao Chief Financial Officer 59 2007
Ji Ye Wu Securities Representative - -
Bao Zhou Duan Board Secretary & Deputy General Manager 55 2008
Qing Fu Director & Deputy General Manager 60 2007
Zeng Liang Chen Director & Deputy General Manager 59 2007
Zi Liang Yang Director & Deputy General Manager 58 2007
Members of the board
Name Title Age Since
Peng Sheng Sun Chairman 63 2007
Feng Shou Wang Chairman-Supervisory Board 60 2007
Xu Sheng Kong Independent Director 61 2016
Lei Zhang Independent Director 49 2016
Guang Ji Wang, Dr. Independent Director 69 2019
Yong He Wu, Dr. Independent Director 65 2019
Qing Fu Director & Deputy General Manager 60 2007
Zeng Liang Chen Director & Deputy General Manager 59 2007
Zi Liang Yang Director & Deputy General Manager 58 2007
Xing Lei Jia Member-Supervisory Board 53 2007
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,007,588,092 456,080,571 45.3% 0 0.0% 45.3%
Shareholders
NameEquities%
Xuzhou Enhua Investment Co. Ltd. 354,126,321 40.3%
Xu Zhang 17,289,900 1.97%
Peng Sheng Sun 12,587,860 1.43%
Wu Sheng Ma 12,442,708 1.42%
Zeng Liang Chen 9,982,148 1.14%
Qing Fu 9,982,147 1.14%
Zi Liang Yang 9,383,109 1.07%
Yanli Li 8,490,760 0.97%
Morgan Stanley Asia Ltd. (Investment Management) 6,884,709 0.78%
First-Trust Fund Management Co., Ltd. 3,617,242 0.41%
Brand Portfolio
In partnership withAllbrands.markets
More brands of Jiangsu Nhwa Pharmaceutical Co., LTD